Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report

Clin Drug Investig. 2020 Nov;40(11):1085-1088. doi: 10.1007/s40261-020-00969-5.
No abstract available

Publication types

  • Letter